Medaica, a digital health company extending the capability of home diagnostics, today announced that the U.S. Food and Drug Administration (FDA)-cleared1 Medaica M1 Telehealth Stethoscope (M1) will be free of charge, starting with qualifying strategic partners supporting rural or underserved patients with chronic heart and/or lung conditions. Continue reading